Suppr超能文献

慢性肾病患者摄入活微生物与全因、心血管疾病及癌症相关死亡率的关联

Association of live microbes intake and risk of all-cause, cardiovascular disease, and cancer-related mortality in patients with chronic kidney disease.

作者信息

Chen Debin, Ye Yongju, Li Yining, Xue Erxu, Zhang Qijun, Chen Youlan, Zhao Jianhui

机构信息

Chronic and Endemic Disease Prevention and Control Division, Xiamen Center for Disease Control and Prevention, Xiamen, China.

Department of Gynaecology, Lishui Hospital of Traditional Chinese Medicine, Lishui, China.

出版信息

Ren Fail. 2025 Dec;47(1):2449196. doi: 10.1080/0886022X.2024.2449196. Epub 2025 Jan 6.

Abstract

BACKGROUND

Chronic kidney disease (CKD) is a prevalent chronic, non-communicable disease. The long-term health effects of dietary live microbes, primarily probiotics, on CKD patients remain insufficiently understood. This study aims to investigate the association between dietary intake of live microbes and long-term health outcomes among individuals with CKD.

METHODS

Utilizing the National Health and Nutrition Examination Survey (NHANES) database, Cox regression analysis assessed the association between medium and high categories dietary live microbe intake and health outcomes (all-cause, cardiovascular disease [CVD], and cancer-related mortality) in CKD patients.

RESULTS

A total of 3,646 CKD patients were enrolled. During the follow-up period, 1,593 all-cause mortality events were recorded, including 478 CVD deaths and 268 cancer deaths. In the fully adjusted model, compared to CKD patients in the lowest quartile (quartile 1) of live microbes intake, those in quartiles 3 and 4 exhibited a 20% and 26% reduced risk of all-cause mortality, with hazard ratios (HR) of 0.80 (95% confidence interval, CI: 0.69, 0.94) and 0.74 (95% CI: 0.62, 0.90), respectively. Additionally, compared to those with low live microbe intake (quartile 1), higher live microbe intake in quartile 4 was associated with a 37% reduction in the risk of CVD mortality for CKD patients, with an HR of 0.63 (95% CI: 0.45, 0.88). Consistent results were observed in subgroup and sensitivity analyses. A significant negative association was observed between live microbe intake and the risk of all-cause mortality as well as CVD mortality in the CKD population, with a p-value for trend < 0.05.

CONCLUSION

Our study indicated that high dietary live microbe intake could mitigate the risk of all-cause and CVD mortality in CKD patients. These findings support the inclusion of live microbes in dietary recommendations, highlighting their significant roles in CKD.

摘要

背景

慢性肾脏病(CKD)是一种常见的慢性非传染性疾病。饮食中活微生物(主要是益生菌)对CKD患者长期健康的影响仍未得到充分了解。本研究旨在调查CKD患者饮食中活微生物摄入量与长期健康结局之间的关联。

方法

利用美国国家健康与营养检查调查(NHANES)数据库,采用Cox回归分析评估CKD患者中高类别饮食活微生物摄入量与健康结局(全因、心血管疾病[CVD]和癌症相关死亡率)之间的关联。

结果

共纳入3646例CKD患者。在随访期间,记录了1593例全因死亡事件,包括478例CVD死亡和268例癌症死亡。在完全调整模型中,与活微生物摄入量处于最低四分位数(四分位数1)的CKD患者相比,处于四分位数3和4的患者全因死亡风险分别降低了20%和26%,风险比(HR)分别为0.80(95%置信区间,CI:0.69,0.94)和0.74(95%CI:0.62,0.90)。此外,与活微生物摄入量低(四分位数1)的患者相比,四分位数4中较高的活微生物摄入量与CKD患者CVD死亡风险降低37%相关,HR为0.63(95%CI:0.45,0.88)。在亚组分析和敏感性分析中观察到一致的结果。在CKD人群中,活微生物摄入量与全因死亡风险以及CVD死亡风险之间存在显著的负相关,趋势p值<0.05。

结论

我们的研究表明,高饮食活微生物摄入量可降低CKD患者的全因和CVD死亡风险。这些发现支持将活微生物纳入饮食建议,突出了它们在CKD中的重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b6/11721851/20897ced531d/IRNF_A_2449196_F0001_C.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验